Clinical trial
BIBX 1382 in Treating Patients With Solid Tumors
NCT00003980 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Suspended
Key facts
| NCT number | NCT00003980 |
|---|---|
| Title | BIBX 1382 in Treating Patients With Solid Tumors |
| Official title | Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BIBX 1382 |
| Enrollment | 80 |
| Start date | Feb 1, 1999 |
| First posted | May 25, 2004 |
| Last update posted | Jul 11, 2012 |
| Countries | Austria, Belgium, Denmark, France, Germany, Netherlands, Norway, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: